Financial Ratios Profarma Distribuidora de Produtos Farmacêuticos S.A.
Stocks
PFRM3
BRPFRMACNOR1
Pharmaceuticals
|
Market Closed -
Sao Paulo
16:03:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 7.180 BRL | +2.72% |
|
+1.84% | -21.36% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.19 | 3.78 | 3.51 | 3.55 | 3.69 | |||||
Return on Total Capital | 3.58 | 6.4 | 6.26 | 6.79 | 7.46 | |||||
Return On Equity % | 5.44 | 5.69 | 5.11 | 7.86 | 7.82 | |||||
Return on Common Equity | 7.33 | 7.1 | 5.77 | 8.98 | 8.98 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 14.15 | 14.66 | 14.92 | 15 | 15.29 | |||||
SG&A Margin | 10.42 | 9.96 | 12.08 | 12.06 | 11.95 | |||||
EBITDA Margin % | 2.54 | 3.64 | 3.41 | 3.37 | 3.53 | |||||
EBITA Margin % | 2.12 | 3.25 | 3.01 | 2.95 | 3.06 | |||||
EBIT Margin % | 2.12 | 3.25 | 3.01 | 2.95 | 3.06 | |||||
Income From Continuing Operations Margin % | 1.23 | 1.09 | 0.9 | 1.21 | 1.1 | |||||
Net Income Margin % | 1.22 | 1.03 | 0.81 | 1.13 | 1.04 | |||||
Net Avail. For Common Margin % | 1.22 | 1.03 | 0.81 | 1.13 | 1.04 | |||||
Normalized Net Income Margin | 0.57 | 0.66 | 0.5 | 0.71 | 0.58 | |||||
Levered Free Cash Flow Margin | -0.17 | -0.73 | -0.19 | 1.57 | 0.58 | |||||
Unlevered Free Cash Flow Margin | 0.57 | 0.46 | 0.97 | 2.49 | 1.67 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.65 | 1.86 | 1.86 | 1.92 | 1.93 | |||||
Fixed Assets Turnover | 14.07 | 15.24 | 16.62 | 16.79 | 15.28 | |||||
Receivables Turnover (Average Receivables) | 8.05 | 8.34 | 7.77 | 7.87 | 7.76 | |||||
Inventory Turnover (Average Inventory) | 5.54 | 5.75 | 5.33 | 5.16 | 4.95 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.5 | 1.52 | 1.45 | 1.34 | 1.29 | |||||
Quick Ratio | 0.86 | 0.88 | 0.81 | 0.72 | 0.68 | |||||
Operating Cash Flow to Current Liabilities | 0.06 | 0.06 | 0.11 | 0.17 | 0.13 | |||||
Days Sales Outstanding (Average Receivables) | 45.34 | 43.78 | 47 | 46.52 | 47.01 | |||||
Days Outstanding Inventory (Average Inventory) | 65.91 | 63.48 | 68.43 | 70.99 | 73.67 | |||||
Average Days Payable Outstanding | 79.55 | 74.16 | 78.75 | 82.35 | 88.13 | |||||
Cash Conversion Cycle (Average Days) | 31.71 | 33.1 | 36.68 | 35.15 | 32.55 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 64.16 | 67.8 | 74.31 | 78.62 | 85.71 | |||||
Total Debt / Total Capital | 39.08 | 40.41 | 42.63 | 44.01 | 46.15 | |||||
LT Debt/Equity | 50.14 | 53.11 | 54.9 | 55.96 | 59.59 | |||||
Long-Term Debt / Total Capital | 30.55 | 31.65 | 31.49 | 31.33 | 32.09 | |||||
Total Liabilities / Total Assets | 63.4 | 65.39 | 68.83 | 71.76 | 73.76 | |||||
EBIT / Interest Expense | 1.79 | 1.7 | 1.61 | 2.01 | 1.74 | |||||
EBITDA / Interest Expense | 3.26 | 2.53 | 2.43 | 3.03 | 2.63 | |||||
(EBITDA - Capex) / Interest Expense | 2.36 | 2.13 | 2.02 | 2.34 | 1.91 | |||||
Total Debt / EBITDA | 3.81 | 2.71 | 2.9 | 2.75 | 2.64 | |||||
Net Debt / EBITDA | 3.05 | 2.22 | 2.41 | 2.25 | 2.2 | |||||
Total Debt / (EBITDA - Capex) | 5.26 | 3.22 | 3.5 | 3.56 | 3.66 | |||||
Net Debt / (EBITDA - Capex) | 4.21 | 2.64 | 2.91 | 2.91 | 3.04 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 17 | 21.88 | 10.82 | 17.22 | 12.77 | |||||
Gross Profit, 1 Yr. Growth % | 18.86 | 26.22 | 12.78 | 17.87 | 14.95 | |||||
EBITDA, 1 Yr. Growth % | 8.54 | 74.65 | 8.16 | 15.73 | 18.21 | |||||
EBITA, 1 Yr. Growth % | 6.23 | 86.25 | 7.47 | 14.76 | 16.85 | |||||
EBIT, 1 Yr. Growth % | 6.22 | 86.27 | 7.48 | 14.76 | 16.85 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 28.02 | 7.49 | -8.45 | 57.74 | 2.61 | |||||
Net Income, 1 Yr. Growth % | 49.41 | 3.43 | -12.95 | 62.76 | 3.77 | |||||
Normalized Net Income, 1 Yr. Growth % | 97.64 | 41.45 | -3.66 | 64.65 | -7.51 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 49.41 | 3.43 | -12.98 | 62.72 | 3.82 | |||||
Accounts Receivable, 1 Yr. Growth % | 9.12 | 25.51 | 13.76 | 17.4 | 11.64 | |||||
Inventory, 1 Yr. Growth % | 20 | 13.92 | 23.63 | 19.17 | 15.09 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 32.19 | -2.32 | 5.64 | 25.88 | 22.27 | |||||
Total Assets, 1 Yr. Growth % | 7.23 | 8.23 | 13.13 | 13.74 | 11 | |||||
Tangible Book Value, 1 Yr. Growth % | 9.46 | 23.78 | 10.31 | 6.87 | 5.33 | |||||
Common Equity, 1 Yr. Growth % | 3.8 | 9.66 | 4.81 | 4.39 | 3.27 | |||||
Cash From Operations, 1 Yr. Growth % | 173.42 | 17.43 | 106.53 | 90.53 | -7.52 | |||||
Capital Expenditures, 1 Yr. Growth % | 90.13 | -12.52 | 12.64 | 51.83 | 43.12 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -57.07 | 424.82 | -73.59 | -1.05K | -58.77 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 120.04 | -1.43 | 186.62 | 200.24 | -24.31 | |||||
Dividend Per Share, 1 Yr. Growth % | - | -35.94 | 122.58 | 49.05 | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 15.57 | 19.41 | 16.22 | 13.98 | 14.98 | |||||
Gross Profit, 2 Yr. CAGR % | 10.91 | 22.48 | 19.31 | 15.3 | 16.4 | |||||
EBITDA, 2 Yr. CAGR % | 13.4 | 37.68 | 34.79 | 11.88 | 16.96 | |||||
EBITA, 2 Yr. CAGR % | 13.66 | 40.66 | 38.43 | 11.06 | 15.8 | |||||
EBIT, 2 Yr. CAGR % | 13.67 | 40.66 | 38.44 | 11.06 | 15.8 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 157 | 17.31 | -0.8 | 20.17 | 27.22 | |||||
Net Income, 2 Yr. CAGR % | 155.5 | 24.31 | -5.12 | 19.03 | 29.96 | |||||
Normalized Net Income, 2 Yr. CAGR % | 255.26 | 67.2 | 8.85 | 25.94 | 23.41 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 155.5 | 24.31 | -5.13 | 19 | 29.98 | |||||
Accounts Receivable, 2 Yr. CAGR % | 22.57 | 17.03 | 19.49 | 15.57 | 14.49 | |||||
Inventory, 2 Yr. CAGR % | 9.92 | 16.92 | 18.68 | 21.38 | 17.11 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 29.22 | 13.64 | 1.58 | 15.31 | 24.06 | |||||
Total Assets, 2 Yr. CAGR % | 12.55 | 7.73 | 10.65 | 13.43 | 12.36 | |||||
Tangible Book Value, 2 Yr. CAGR % | 10.84 | 16.4 | 16.85 | 8.58 | 6.1 | |||||
Common Equity, 2 Yr. CAGR % | 3.97 | 6.69 | 7.21 | 4.6 | 3.83 | |||||
Cash From Operations, 2 Yr. CAGR % | -8.18 | 79.18 | 55.73 | 98.37 | 32.74 | |||||
Capital Expenditures, 2 Yr. CAGR % | 78.81 | 28.97 | -0.73 | 30.77 | 47.41 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -36.1 | 50.1 | 24.54 | 58.23 | 97.68 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 7.84 | 47.27 | 51.52 | 193.35 | 50.74 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | 19.41 | 82.14 | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 14.51 | 17.64 | 16.48 | 16.55 | 13.57 | |||||
Gross Profit, 3 Yr. CAGR % | 10.05 | 15.79 | 19.16 | 18.83 | 15.18 | |||||
EBITDA, 3 Yr. CAGR % | 29.37 | 30.96 | 25.4 | 28.11 | 13.95 | |||||
EBITA, 3 Yr. CAGR % | 35.56 | 34 | 26.73 | 30.04 | 12.95 | |||||
EBIT, 3 Yr. CAGR % | 35.58 | 34.01 | 26.74 | 30.04 | 12.95 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 101.06 | 92.2 | 8.01 | 15.79 | 14.01 | |||||
Net Income, 3 Yr. CAGR % | 100.27 | 89.01 | 10.39 | 13.58 | 13.71 | |||||
Normalized Net Income, 3 Yr. CAGR % | 27.62 | 161.35 | 32.8 | 24.95 | 13.63 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 97.25 | 89.01 | 10.38 | 13.56 | 13.71 | |||||
Accounts Receivable, 3 Yr. CAGR % | 15.1 | 23.54 | 15.93 | 18.79 | 14.24 | |||||
Inventory, 3 Yr. CAGR % | 10.9 | 11.24 | 19.12 | 18.84 | 19.25 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 59.09 | 17.71 | 10.91 | 9.11 | 17.59 | |||||
Total Assets, 3 Yr. CAGR % | 11.75 | 11.1 | 9.5 | 11.67 | 12.62 | |||||
Tangible Book Value, 3 Yr. CAGR % | 9.67 | 14.99 | 14.33 | 13.42 | 7.48 | |||||
Common Equity, 3 Yr. CAGR % | 2.07 | 5.84 | 6.06 | 6.26 | 4.16 | |||||
Cash From Operations, 3 Yr. CAGR % | 24.43 | -0.34 | 87.87 | 66.56 | 53.82 | |||||
Capital Expenditures, 3 Yr. CAGR % | 78.34 | 40.9 | 23.28 | 14.37 | 34.76 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -8.38 | 28.92 | -12.68 | 144.98 | 1.06 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 10.09 | 4.66 | 71.59 | 90.32 | 86.75 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | 28.57 | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.44 | 13.77 | 15.19 | 16.16 | 15.87 | |||||
Gross Profit, 5 Yr. CAGR % | 7.74 | 10.32 | 13.67 | 15.59 | 18.05 | |||||
EBITDA, 5 Yr. CAGR % | 9.96 | 64.86 | 31.52 | 22.01 | 21.96 | |||||
EBITA, 5 Yr. CAGR % | 10.76 | 99.01 | 36.7 | 23.22 | 22.24 | |||||
EBIT, 5 Yr. CAGR % | 10.76 | 99.01 | 36.71 | 23.23 | 22.24 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 10.07 | -5.48 | 51.57 | 59.28 | 15.32 | |||||
Net Income, 5 Yr. CAGR % | 9.81 | -6.42 | 48.54 | 57.09 | 17.84 | |||||
Normalized Net Income, 5 Yr. CAGR % | 2.32 | -11.55 | 19.75 | 89.79 | 28.96 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -4.95 | -15.82 | 47.19 | 57.07 | 17.84 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9.54 | 17.63 | 16.84 | 20.29 | 15.35 | |||||
Inventory, 5 Yr. CAGR % | 10.8 | 14.41 | 13.95 | 15.19 | 18.31 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 35.88 | 30.1 | 32.96 | 16.75 | 15.99 | |||||
Total Assets, 5 Yr. CAGR % | 8.26 | 10.75 | 11.31 | 12.02 | 10.64 | |||||
Tangible Book Value, 5 Yr. CAGR % | 68.61 | 54.92 | 12.49 | 12.38 | 10.96 | |||||
Common Equity, 5 Yr. CAGR % | 7.43 | 9.81 | 4.1 | 5.34 | 5.16 | |||||
Cash From Operations, 5 Yr. CAGR % | 0.05 | 19.5 | 36.11 | 31.25 | 63.5 | |||||
Capital Expenditures, 5 Yr. CAGR % | 19.54 | 4.66 | 41.08 | 36.76 | 32.42 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -34.72 | -16.65 | 3.59 | 43.11 | 21.08 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 38.94 | -1.84 | 25.1 | 51.63 | 62.93 |
Select your edition
All financial news and data tailored to specific country editions
















